Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanoma.

Source:http://linkedlifedata.com/resource/pubmed/id/19884534

J. Clin. Oncol. 2009 Dec 1 27 34 5763-71

Download in:

View as

Triples

General Info

PMID
19884534